Skip to main content
BIOMERICA INC logo

BIOMERICA INC — Investor Relations & Filings

Ticker · BMRA ISIN · US09061H3075 US Manufacturing
Open in API
Filings indexed 587 across all filing types
Latest filing 2025-10-08 Board/Management Inform…
Country US United States of America
Listing US BMRA

About BIOMERICA INC

https://biomerica.com/

Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced in-vitro diagnostic (IVD) and therapeutic products. The company provides solutions for both laboratory and at-home testing, designed for the early detection and monitoring of chronic conditions. Its primary research and development focus is on gastrointestinal and inflammatory diseases, with a notable pipeline that includes a non-drug, diagnostic-guided therapy for Irritable Bowel Syndrome (IBS). Biomerica's products aim to enhance patient health and well-being while contributing to the reduction of total healthcare costs.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details changes in the company's board of directors, including the appointment of a new director and the decision of an existing director not to stand for re-election. It includes biographical information about the new director, committee assignments, and compensation details. There is no financial data or comprehensive report content, but rather an announcement of management changes. This fits the category of Board/Management Information (MANG). The document length is 7665 characters, which is consistent with a detailed 8-K filing but not a full annual or quarterly report. Therefore, the correct classification is MANG with high confidence.
2025-10-08 English
10-K/A
Annual Report FY 2025
2025-09-26 English
10-K
Annual Report FY 2025
2025-08-29 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 4, 2025, for Biomerica, Inc. The key content is the announcement of a change in the company's board of directors: a director resigned and a new independent director was appointed. The document includes details about the new director's qualifications, compensation, and committee assignments. There are no financial statements or detailed financial data presented. The primary focus is on management/board changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 6707 characters, which is sufficient to contain substantive information about the board change, not just a brief announcement or a report publication notice. Therefore, the correct classification is MANG with high confidence.
2025-06-06 English
Director's Dealing 2025
Director's Dealing
2025-06-06 English
Share Issue/Capital Change 2025
Share Issue/Capital Change Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated April 15, 2025, by Biomerica, Inc. It details a corporate action: a reverse stock split approved by the Board and stockholders, including the filing of an amendment to the Certificate of Incorporation to effect the reverse split. The document includes legal and regulatory disclosures, a press release about the reverse stock split, and the amendment as an exhibit. There are no financial statements or detailed financial data presented. The primary content is an announcement of a capital structure change (reverse stock split). According to the filing definitions, announcements about stock splits or other capital changes fall under "Share Issue/Capital Change (SHA)". The document is not a full financial report, earnings release, or management discussion, but a regulatory announcement of a capital change event. Therefore, the correct classification is SHA with high confidence.
2025-04-16 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.